Edward Yu
Overview
Explore the profile of Edward Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
1976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hu Y, Liu G, Yu E, Wang B, Wittenbecher C, Manson J, et al.
Diabetes Care
. 2023 Feb;
46(4):874-884.
PMID: 36787923
Objective: The current study aims to prospectively examine the association between postdiagnosis low-carbohydrate diet (LCD) patterns and mortality among individuals with type 2 diabetes (T2D). Research Design And Methods: Among...
12.
Sur R, Pond G, Falkson C, Pan M, Wright J, Bezjak A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jan;
116(3):601-610.
PMID: 36610615
Purpose: Uncontrolled studies suggest that the addition of high-dose-rate intraluminal brachytherapy (HDRIB) to external beam radiation therapy (EBRT) may improve palliation for patients with advanced non-small cell lung cancer (NSCLC)....
13.
Falkson C, Vella E, Ellis P, Maziak D, Ung Y, Yu E
J Thorac Oncol
. 2022 Nov;
18(3):299-312.
PMID: 36343922
Introduction: Thymic epithelial tumors are rare and are classified as thymoma, thymic carcinoma, and thymic neuroendocrine tumors. The objective of this systematic review was to evaluate the treatment options for...
14.
Falkson C, Vella E, Ellis P, Maziak D, Ung Y, Yu E
J Thorac Oncol
. 2022 Aug;
17(11):1258-1275.
PMID: 36031176
Introduction: The aim of this guideline was to provide recommendations for the most effective therapy for patients with thymic epithelial tumors, including thymoma, thymic carcinoma, and thymic neuroendocrine tumors (NETs)....
15.
Yu E, Allan A, Sanatani M, Lewis D, Warner A, Dar A, et al.
BMC Cancer
. 2022 Jul;
22(1):746.
PMID: 35804307
Background: Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal cancer undergoing tri-modality therapy. Methods: We prospectively collected CTC...
16.
Malthaner R, Yu E, Sanatani M, Lewis D, Warner A, Dar A, et al.
Thorac Cancer
. 2022 May;
13(13):1898-1915.
PMID: 35611396
Background: We compared the health-related quality of life (HRQOL) in patients undergoing trimodality therapy for resectable stage I-III esophageal cancer. Methods: A total of 96 patients were randomized to standard...
17.
Yaremko B, Capaldi D, Sheikh K, Palma D, Warner A, Dar A, et al.
Int J Radiat Oncol Biol Phys
. 2022 May;
113(5):1072-1084.
PMID: 35550405
Purpose: To determine whether functional lung avoidance based on He magnetic resonance imaging (MRI) improves quality of life (QOL) for patients undergoing concurrent chemoradiotherapy (CCRT) for advanced non-small cell lung...
18.
Hajtovic S, Yu E, Bershadskiy A, Sacho R, Gilad R
Surg Neurol Int
. 2022 May;
13:181.
PMID: 35509545
Background: Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal subtype of nonHodgkin's lymphoma. Ventricle-predominant PCNSL, arising in the CNS ventricular system, is a rare entity. In over 90%...
19.
Chau O, Islam A, Yu E, Qu M, Butler J, Biernaski H, et al.
Adv Radiat Oncol
. 2022 Apr;
7(4):100927.
PMID: 35434423
No abstract available.
20.
Yakoby J, Litvak I, Yu E
J Emerg Med
. 2021 Jun;
61(4):e67-e70.
PMID: 34103203
Background: Novel coronavirus disease 2019 (COVID-19) has affected more than 89 million people worldwide. As the pandemic rages on, more complications of the disease are being recognized, including stroke, cardiovascular...